Amparo and 3XP Global: Partnering to Redefine Prosthetic Care Worldwide

At Amparo Prosthetics, we’ve always believed that innovation means little if it can’t reach the people who need it most. That belief has guided us from day one—driving our mission to make high-quality, comfortable prosthetic care accessible anywhere in the world.

Now, we’re thrilled to announce a major milestone in that journey: Amparo has secured a strategic investment from 3XP Global through their Impact Innovation Fund. This partnership marks a new chapter for us—one focused on growth, impact, and expanding access to mobility across every corner of the globe.

A Shared Vision for Change

3XP Global backs companies that drive meaningful, measurable impact. Their belief in combining innovation with purpose aligns perfectly with our mission: creating prosthetic technology that restores mobility, independence, and confidence for people with limb loss.

With more than 5,000 Amparo sockets fitted across 40+ countries, our direct-fit solutions are helping clinicians provide prosthetic care faster, more efficiently, and more comfortably—often in under two hours. But this investment is about more than scaling our products; it’s about scaling our impact.

“This investment is a pivotal step in Amparo’s journey to scale globally,”
says Frederico Carpinteiro, CEO of Amparo Prosthetics.
“With expanded manufacturing, distribution, and continued R&D, we’re building the infrastructure for sustainable growth and global impact.”

What This Partnership Means for the Future

The 3XP Global investment strengthens Amparo’s ability to innovate and expand on multiple fronts:

• Manufacturing Expansion: We’re opening a production facility in Portugal, reducing production costs and increasing our ability to meet growing global demand.

• R&D Acceleration: Development continues on cutting-edge technologies like Majicast, our hydrostatic fitting system, and the Asha Socket, designed to bring affordable prosthetic care to low-resource settings.

• Global Reach: With 3XP Global’s support, we’re expanding distribution networks and partnerships, bringing Amparo solutions to even more clinics and humanitarian projects.

• Data-Driven Care: Through Motio StepWatch and Functional Reports, we’re empowering clinicians with real-world insights to improve patient outcomes.

“This partnership strengthens our ability to advance socket technology through engineering and innovation,”
adds Wesley Teerlink, CTO of Amparo.
“With Majicast and new product lines like the Asha Socket, we’re creating scalable solutions that deliver consistent, reliable outcomes.”

Transforming Prosthetic Care — One Fit at a Time

Every step we take is guided by a simple truth: mobility changes lives.
From advanced healthcare systems to conflict zones and rural communities, our technology makes it possible for clinicians to fit high-quality prosthetics anywhere—without the need for labs, plaster, or repeated visits.

This new partnership with 3XP Global enables us to reach more people, innovate faster, and continue redefining what’s possible in prosthetic care. Together, we’re not just building better sockets—we’re building a future where independence is accessible to all.

Read More

To learn more about the partnership and what this means for the future of prosthetic innovation, read the full announcement from 3XP Global:
👉 3XP Global Invests in Amparo to Redefine Prosthetic Care Worldwide